CATEGORY HUB
Eye
Eye verdicts ranked by evidence score. 121 verdicts in this category.
43 foods and supplements claimed to help eye health, ranked by evidence
Drugs and procedures removed — only what you swallow, ordered by how strong the evidence is.
Eye Evidence Ranking
Within this category, verdicts with higher evidence scores appear first. Verdicts without a score stay lower in the same list.
| A | 90 | Panretinal photocoagulation (PRP, standard retinal laser, prescribed procedure) | Prevention of severe visual loss and blindness in high-risk proliferative diabetic retinopathy |
| A | 90 | Focal or grid retinal laser photocoagulation (prescription ophthalmic procedure) | Prevention of moderate vision loss in clinically significant diabetic macular edema |
| A | 88 | Ranibizumab (anti-VEGF monoclonal antibody, intravitreal injection, prescription medicine) | Improved vision and reduced vision loss in center-involved diabetic macular edema |
| A | 86 | An additional 40 minutes outdoors on school days | Reduced first onset of myopia in children without baseline myopia |
| A | 82 | Cefuroxime sodium 1 mg/0.1 mL intracamerally (second-generation cephalosporin; approval status varies by country) | Prevention of postoperative endophthalmitis when injected into the anterior chamber at the end of cataract surgery |
| B | 79 | Latanoprost (Xalatan, prescription eye drops) | Slowing progression of visual-field loss in open-angle glaucoma |
| B | 79 | Aflibercept (prescription intravitreal anti-VEGF injection; Eylea) | Prevention of vision loss and improvement of vision in neovascular age-related macular degeneration |
| B | 78 | Bimatoprost (a prescription prostamide ocular hypotensive; Lumigan) | Lowering of intraocular pressure in open-angle glaucoma and ocular hypertension |
| B | 78 | Acyclovir or aciclovir (prescription oral guanosine-analogue antiviral) | Prevention of recurrent ocular HSV and stromal keratitis in adults with recent ocular herpes simplex disease |
| B | 78 | Fenofibrate (PPAR-alpha agonist, prescription drug; retinopathy use is off-label in many jurisdictions) | Reduced progression of diabetic retinopathy and need for first laser treatment in type 2 diabetes |
| B | 77 | Selective laser trabeculoplasty (SLT, 532-nm frequency-doubled Q-switched Nd:YAG ophthalmic procedure) | Reduced disease progression and need for incisional glaucoma surgery as first-line treatment for open-angle glaucoma or ocular hypertension |
| B | 75 | Timolol maleate (prescription nonselective beta-blocker ophthalmic drug) | Lowered intraocular pressure in open-angle glaucoma and ocular hypertension |
| B | 74 | Faricimab (dual VEGF/Ang-2 antibody, Vabysmo, prescription medicine) | Maintenance of visual improvement with dosing intervals up to 16 weeks in wet age-related macular degeneration |
| B | 74 | Bevacizumab (prescription anti-VEGF monoclonal antibody; off-label ophthalmic use) | Improved vision and macular thickness with intravitreal injection in center-involved diabetic macular edema |
| B | 74 | Verteporfin (benzoporphyrin photosensitizer for photodynamic therapy, Visudyne, prescription infusion plus laser procedure) | Prevention of moderate or severe vision loss in wet age-related macular degeneration with classic choroidal neovascularization |
| B | 74 | Adhesive occlusion patch for amblyopia (non-drug ophthalmic product) | Visual-acuity improvement and treatment success in residual childhood amblyopia after refractive correction |
| B | 74 | Early pars plana vitrectomy (vitreoretinal microsurgery, prescription procedure) | Prevention of long-term severe visual loss and recovery of useful vision in severe vitreous hemorrhage and proliferative diabetic retinopathy in type 1 diabetes |
| B | 74 | Immediate pars plana vitrectomy (prescribed vitreoretinal surgery) | Prevention of severe visual loss in eyes with light-perception-only vision from bacterial endophthalmitis after cataract surgery |
| B | 72 | Docosahexaenoic acid (DHA), retinal and visual-development axis | Maintenance of retinal function and infant visual development |
| B | 72 | Bromfenac ophthalmic solution (prescription topical NSAID; Bronuck) | Reduced anterior-segment inflammation and ocular pain after cataract surgery |
| B | 72 | Phacoemulsification with intraocular-lens implantation (prescription cataract surgery) | Reduced recurrent falls, fall rate, and fracture risk in visually impaired older women |
| B | 72 | Daily-wear reusable soft contact lenses that are cleaned and stored for reuse | Higher incidence of Acanthamoeba keratitis, a form of microbial keratitis, than with daily disposable lenses |
| B | 71 | Olopatadine hydrochloride ophthalmic solution (prescription H1 antihistamine and mast-cell stabilizer) | Relief of ocular itching and redness in seasonal allergic conjunctivitis |
| B | 70 | Zinc in the AREDS and AREDS2 context | Reduced risk of intermediate age-related macular degeneration progressing to advanced disease and central vision loss |
| B | 70 | Sleeping in standard soft, approved extended-wear silicone-hydrogel, or rigid contact lenses | Increased microbial keratitis |
| B | 70 | Antibiotic-corticosteroid ear drops for acute otorrhea in children with tympanostomy tubes | Improved otorrhea resolution and clinical cure versus oral amoxicillin-clavulanate or observation |
| B | 69 | Ketotifen fumarate ophthalmic solution (nonprescription antihistamine and mast-cell stabilizer) | Relief of ocular itching and tearing from seasonal allergic conjunctivitis |
| B | 68 | Nepafenac (prescription ophthalmic NSAID; Nevanac) | Prevention of macular edema and visual loss after cataract surgery in patients with diabetic retinopathy |
| B | 68 | Moxifloxacin 0.5% ophthalmic solution, a prescription fourth-generation fluoroquinolone antibiotic marketed as Vigamox | Clinical cure and eradication of causative bacteria in bacterial conjunctivitis |
| B | 68 | Levofloxacin 0.5% ophthalmic solution, a prescription fluoroquinolone antibiotic marketed as Cravit | Clinical cure and eradication of causative organisms in bacterial conjunctivitis |
| B | 68 | Dexamethasone intravitreal implant (prescription corticosteroid implant; Ozurdex) | Clinically meaningful visual recovery of at least 15 letters in macular edema due to retinal vein occlusion |
| B | 68 | Riboflavin-UVA corneal collagen cross-linking (CXL, a photochemical ophthalmic procedure) | Prevention of corneal protrusion or K-value progression and visual deterioration in progressive keratoconus |
| B | 68 | Intravitreal bevacizumab | Noninferior 6-month vision versus aflibercept in macular edema from retinal vein occlusion |
| B | 65 | Travoprost 0.004%, a prescription ophthalmic prostaglandin F2-alpha analogue | Reduction of intraocular pressure in open-angle glaucoma and ocular hypertension |
| B | 64 | Dorzolamide 2% (prescription topical carbonic anhydrase inhibitor ophthalmic solution; Trusopt) | Lower intraocular pressure in open-angle glaucoma and ocular hypertension |
| B | 62 | Brinzolamide 1% (topical carbonic anhydrase inhibitor ophthalmic prescription medicine) | Lower intraocular pressure in open-angle glaucoma and ocular hypertension |
| B | 60 | Vitamin A (retinol/beta-carotene) | Eye health, night blindness, skin, and immunity |
| B | 60 | Maqui berry extract (Aristotelia chilensis) | Improvement in dry eye and tear production |
| B | 60 | Brolucizumab (anti-VEGF-A single-chain antibody fragment, Beovu, prescription intravitreal injection) | Improved vision and prevention of vision loss in neovascular age-related macular degeneration |
| C | 59 | Palmitoylethanolamide (PEA) | Adjunctive support for intraocular pressure and glaucoma |
| C | 59 | Low-dose atropine 0.05% (prescription ophthalmic drops) | Slowed childhood myopia progression and axial elongation |
| C | 58 | Tisochrysis lutea powder | Improvement of dry-eye symptoms and tear secretion |
| C | 58 | Trehalose ophthalmic solution (cytoprotective artificial tear) | Improvement of dry-eye symptoms and tear-film stability |
| C | 58 | Diquafosol sodium ophthalmic solution (Diquas, prescription medicine) | Improvement of dry-eye symptoms by increasing fluid and mucin secretion |
| C | 57 | Grape-skin enzymatic fermented extract (KL-GEFE) | Improvement of dry eye and tear-film measures |
| C | 57 | Rebamipide eye drops (Rebaeye, prescription) | Improvement of dry-eye symptoms and corneoconjunctival epithelial damage by promoting mucin secretion |
| C | 56 | Centella asiatica extract powder | Maintenance of macular pigment density and eye health |
| C | 56 | Pilocarpine hydrochloride 1.25% ophthalmic solution (muscarinic agonist, VUITY, prescription eye drops) | Improved near vision for several hours after dosing in adults with presbyopia |
| C | 55 | Astaxanthin (astaxanthin, Haematococcus extract) | eye fatigue, skin health, and antioxidant effects |
| C | 55 | Sodium hyaluronate ophthalmic solution (artificial tears) | Improvement of dry-eye symptoms and tear-film stability |
| C | 55 | Repeated low-level red-light therapy (RLRL, desktop ophthalmic light-treatment device) | Slowed axial elongation and refractive progression in children with myopia |
| C | 55 | High-add multifocal soft contact lenses (peripheral-add optical lenses with +2.50 D add power) | Slowed refractive progression and axial elongation in childhood myopia |
| C | 54 | Saffron extract | Visual function and contrast sensitivity in age-related macular degeneration |
| C | 54 | Carboxymethylcellulose sodium eye drops (CMC, Refresh, nonprescription) | Improvement of dry-eye symptoms, irritation, and tear-film instability |
| C | 54 | Daily digital screen time | Higher myopia risk in children and adolescents |
| C | 54 | Immediate sequential bilateral cataract surgery | Achievement of refractive target versus delayed sequential surgery |
| C | 52 | Cyclosporine ophthalmic emulsion (Restasis, prescription medicine) | Improved tear production and symptoms in inflammatory dry eye |
| C | 52 | DIMS defocus spectacle lenses (Defocus Incorporated Multiple Segments; MiyoSmart; a peripheral myopic-defocus optical medical device) | Reduced two-year refractive progression and axial elongation in children with myopia |
| C | 50 | Lutein and zeaxanthin | macular health and eye health |
| C | 50 | Vitamin D3 (cholecalciferol, fat-soluble vitamin supplement) | Improvement in OSDI, tear-film stability, and tear secretion in patients with dry eye and vitamin D deficiency |
| C | 50 | Orthokeratology overnight corneal-reshaping lens | Slower childhood myopia progression and axial elongation |
| C | 50 | Lifitegrast 5% ophthalmic solution, an LFA-1 antagonist | Improved eye-dryness and ocular-discomfort symptoms |
| C | 50 | Raw vegetable salad eaten with 0, 75, or 150 g scrambled whole egg | Increased 10-hour plasma TRL AUC for total and individual carotenoids |
| C | 50 | Pre-moistened eyelid-cleansing wipe containing aloe, purslane extract, panthenol, and surfactants | Reduction of blepharitis-associated ocular symptoms |
| C | 50 | A workplace hearing-conservation program with sustained use of hearing protection | Reduced standard hearing-threshold shifts |
| C | 50 | A photocatalytic micro-mist desktop humidifier operated near the face during a visual display terminal task | Longer noninvasive tear-film breakup time after one hour of screen work |
| C | 50 | Glasses with pads containing ethanol extracts of four medicinal plants | Reduced OSDI symptoms in mild dry eye |
| C | 49 | Persimmon-leaf ethanolic extract | Improvement of dry eye |
| C | 49 | Nicotinamide or niacinamide (high-dose oral supplement) | Improved retinal ganglion-cell function and short-term visual function in glaucoma during intraocular-pressure-lowering treatment |
| C | 47 | Purple corn cob and husk extract powder | Improvement of dry eyes |
| C | 46 | Bilberry extract (anthocyanins/anthocyanosides) | eye fatigue, eye health, vision/night vision, and dry-eye-related claims |
| C | 46 | Meso-zeaxanthin | Increased macular pigment, improved contrast sensitivity, and reduced glare disability |
| C | 46 | Mirtogenol combination (Mirtoselect bilberry plus Pycnogenol) | Lower intraocular pressure and slowed glaucoma progression |
| C | 46 | Tafluprost (prostaglandin F2 alpha analogue eye drops, Taflotan, prescription drug) | Slowing progression of glaucomatous visual-field loss beyond lowering intraocular pressure |
| C | 46 | Pegcetacoplan 15 mg intravitreal injection | Slowed geographic atrophy lesion enlargement in nonexudative age-related macular degeneration |
| C | 46 | Avacincaptad pegol (Izervay, intravitreal injection) | Slowed geographic atrophy lesion enlargement in age-related macular degeneration |
| C | 46 | Raw vegetable salad with dressings containing 0, 2, 4, 8, or 32 g soybean oil | Increased postprandial chylomicron carotenoid AUC and peak concentration |
| C | 46 | A unilateral inferior punctal plug in prostaglandin-treated glaucoma patients | Improvement in ocular-surface symptoms and tear-film measures |
| C | 46 | Prescription-matched free eyeglasses delivered directly at school | Improved end-of-year mathematics scores compared with prescription-only access |
| C | 46 | A botanical formula containing lutein ester, zeaxanthin, blackcurrant, chrysanthemum, and goji berry extracts | Reduced digital eye fatigue in adults using video displays |
| C | 45 | Perilla leaf extract | Eye-fatigue relief |
| C | 45 | Nicotinamide (niacinamide, the amide form of vitamin B3) | High-dose supplementation to slow long-term visual-field loss in open-angle or normal-tension glaucoma |
| C | 44 | Sea buckthorn oil (Hippophae rhamnoides) | Dry-eye symptoms and tear-film improvement |
| C | 44 | Valacyclovir (prescription guanosine antiviral prodrug; Valtrex) | Prevention of recurrent keratitis and iritis with one year of suppressive therapy after herpes zoster ophthalmicus |
| C | 43 | Goji berry (wolfberry, Lycium barbarum/goji berry) | Eye, fatigue, immunity, antioxidant |
| C | 43 | Gardenia-derived crocetin | Improvement of eye fatigue and accommodation |
| C | 42 | Dried Tetraselmis chuii powder | Improvement of dry eye and tear secretion |
| C | 40 | Blackcurrant anthocyanins | VDT-related eye fatigue and dark adaptation |
| C | 40 | Cyanidin-3-glucoside-rich black soybean seed-coat extract | Eye fatigue and accommodative function |
| C | 40 | Brimonidine ophthalmic solution (alpha-2 agonist eye drop, Alphagan, prescription) | Neuroprotection beyond intraocular-pressure lowering that inhibits visual-field progression in normal-tension glaucoma |
| C | 40 | Saffron extract (Crocus sativus; crocin-containing botanical extract and supplement) | Lowering intraocular pressure and inhibiting progression when added to existing eye-drop treatment for primary open-angle glaucoma |
| C | 40 | LipiFlow thermal pulsation (ophthalmic medical-device procedure) | Improvement of symptoms and tear-film measures in meibomian-gland-dysfunction dry eye |
| D | 36 | Eyelid warming mask (a moist-heat or steam non-drug eye-care product) | Improved dryness, foreign-body sensation, and tear-film stability in evaporative dry eye caused by meibomian gland dysfunction |
| D | 35 | Bates-type eye exercises (device-free vision training) | Reduced myopic refractive power and permanently restored unaided vision through repeated training |
| D | 35 | Intense pulsed light therapy (IPL, ophthalmic procedure) | Improved tear-film measures and symptoms in dry eye due to meibomian gland dysfunction |
| D | 34 | Citicoline or CDP-choline (phospholipid precursor, supplement and medicine in some countries) | Adjunctive inhibition of glaucomatous visual-field progression during pressure-lowering treatment |
| D | 34 | Femtosecond laser-assisted cataract surgery (FLACS) | Superior three-month uncorrected distance visual acuity versus phacoemulsification |
| D | 32 | Omega-3 (EPA/DHA) | Dry eye disease |
| D | 30 | Yellow-lens night-driving glasses | Faster pedestrian detection under headlight glare |
| D | 30 | Rinsing, cleaning, or storing contact lenses in tap water | Safe use without increased Acanthamoeba or fungal keratitis |
| D | 30 | Air-travel earplugs containing a pressure-regulating filter | Prevention of ear pain and middle-ear barotrauma during aircraft descent |
| D | 30 | Routine water precautions after pediatric tympanostomy tubes, using earplugs during bathing and swimming or avoiding swimming | Prevention of tympanostomy-tube otorrhea within one year |
| D | 28 | Pirenoxine eye drops (Kary Uni or Catalin, prescription) | Slowing progression of early senile cataract |
| D | 28 | Looking about 20 feet away for 20 seconds every 20 minutes | Relief of digital eye strain and dry-eye symptoms |
| D | 28 | Eye patching for simple corneal abrasion | Faster healing and less pain |
| D | 28 | Tea tree oil eyelid scrub | Symptom improvement in Demodex blepharitis |
| D | 27 | Marine omega-3 EPA and DHA from fish-oil supplements | Improvement of dry-eye symptoms and tear-film status |
| D | 25 | Lutein and zeaxanthin (xanthophyll carotenoid supplements) | Prevention of age-related cataract progression, moderate vision loss, and cataract surgery |
| D | 24 | N-acetylcarnosine eye drops (NAC eye drops, Can-C) | Reversal or slowed progression of age-related cataract and restoration of vision |
| D | 24 | Pinhole glasses (non-drug multiple-aperture optical vision-training product) | Permanent reduction of myopic refractive error and restoration of unaided vision through continued wear |
| D | 23 | Ginkgo biloba extract (flavonoid- and terpene-lactone supplement or herbal medicine) | Lower intraocular pressure and slower visual-field loss in normal-tension glaucoma |
| D | 22 | Omega-3 fatty acids (EPA and DHA; fish-oil supplement) | Suppression of age-related macular degeneration progression and vision loss when added to an AREDS formulation |
| F | 10 | Blue-light filtering spectacles (non-drug optical filters) | Relief of eye strain and dry eye and protection of the retina in digital-screen users |
| F | 10 | Vitamin C (oral 500 mg/day supplement) | Long-term prevention of age-related cataract onset, progression, and cataract surgery |
| F | 8 | High-dose vitamin E (alpha-tocopherol 400 to 600 IU, a fat-soluble antioxidant vitamin supplement and ingredient in some nonprescription products) | Reduced incidence and progression of age-related cataract and lower risk of cataract surgery |
| ? | score not listed | Chrysanthemum flower (Chrysanthemum indicum) | Eye-fatigue relief and vision protection |
| ? | score not listed | Eyebright (Euphrasia officinalis) | Eye-fatigue relief and vision protection |
| ? | score not listed | Bromelain (vitreous-floater efficacy claim) | Reduction of vitreous floaters and opacities |
| ? | score not listed | Self-instillation of 100% castor oil (ricinoleic-acid-rich plant oil; nonsterile general-purpose oil) | Dissolution or reversal of age-related cataract with restored vision after ocular instillation |
| ? | score not listed | Whole carrots or carrot juice (Daucus carota) | Improved vision in people with normal sight and no vitamin A deficiency |
| ? | score not listed | Whole bell peppers and sweet peppers | Improved eye fatigue and visual function |